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24% (427) and positive in 12% (213). There were no adverse effects of IET. There were 
1608 Pts with O-1 ACF and 176 with 2-3 ACF. MultIpIe ACF predicted a positive or ND 
IET: 2 ACF (RR 4.2, Cl 2.6-6.3) and 3 ACF (RR 2.7, Cl 0.8-9.0). At 30 day FU there were 
no deaths and total cardiac events (non-Q Ml + revascularization) were: Pts with O-l ACF 
- 1.7%; Pts with 2-3 ACF - 7.0%. Revascularizatlon comprised 81% (30137) of all events. 
CONCLUSION: Aggregation of ACF is associated wth an increase in positive IET and 
cardiac events. However, there were no deaths and the number of events was very low, 
the majority of which were revascularization. Patients with ACF can be safely managed 
by the accelerated protocol in our CPEU. 
1072-l 03 Decline in Recurrent lschemic Events After Myocardial 
infarction: A 20-Year Community Study 
Maan Jokhadar, Steven J. Jacobsen, Guy S. Reeder, Susan A. Weston, Ryan 
Meverden, Jill M. Killian, Veronique L. Roger, Mayo Clinic, Rochester, MN 
Background: Despite use of efficacious interventions for secondary prevention after 
myocardial infarction (MI), little is known about their effect on the long-term incidence of 
recurrent ischemic events after Ml. This study tested the hypothesis that recurrent 
lschemic events after incident Ml declined over time. 
Methods: Standard epidemiological criteria were used to validate all incident MIS in Olm- 
sted County between 1979 and 1996. Recurrent ischemic events defined as recurrent 
MI. unstable angina requiring hospitalization (UA) and sudden cardiac death (SCD), were 
idenbfied through the community medical record. 
Results: Between 1979 and 1998, 2277 incident Ml cases occurred I” Olmsted County 
(57% men; mean age, 672 14 years). After 6.3i 5.3 years of follow-up, there were 566 
recurrent MIS, 1025 UA, and 230 SCDs. The B-year event-free survival was 77% (95% 
Cl, 75%-79%) for recurrent MI, 53% (95% Cl%, 51.55%) for UA, and 93% (95% Cl, 92%. 
94%) for SCD. 
The table presents the relative risk (RR) of recurrent ischemlc events over time using 
subjects with Ml between 1979 and 1963 as the referent. Overall, all recurrent ischemic 
events decreased over bme, in earlier years largely due to decline in recurrent Ml and UA 
whereas in most recent years, a marked decline in SCD occurred. 
Conclusion: Over the past 2 decades, the occurrence of recurrent lschemic events after 
incident Ml declined over time. most likely reflecting advances in therapy and secondary 
prevention. 
sion had occurred asymptomatically. 
Conclusions: After demonstrated coronary patency following fibrinolytic therapy, 
patients who survived the first 48 hours had an excellent IO-year prognosis. Whereas 
reocclusion was associated with a markedly increased risk of cardiac mortality, even in 
case of asymptomatic reocclus~on. all cause mortality did not differ from patients with 
sustained patency. 
1072-101 Management and Outcomes of Patients With Acute 
Coronary Syndromes: One-Year Results From the 
Canadian Acute Coronary Syndrome Registry 
Andrew T. Yan Shaun G. Goodman, Mary Tan. David Fltchett, Chi-Ming Chow, Anatoly 
Langer, Canadian ACS Registry Investigators, University of Toronto and Canadian Healt 
Research Centre, Toronto, ON, Canada 
Background: While clinical trials provide evidence for the management of acute core- 
nary syndromes (ACS), these results may not be applicable to a wider patient population. 
There are limited data regarding the actual management and outcomes of patients dis- 
charged from hospitals following an ACS. 
Methods: The ACS Registry IS a prospective Canadian observational study of 5312 
patients wth suspected ACS from 51 centres in 9 provinces. A final diagnosis of ACS 
was determined in 4627 patients (87.1%). Vital status at l-year was available for 4329 
patients (6% lost to follow-up). Non-fatal cardiac events (myccardial infarction=Ml; unsta- 
ble angina=UA), angiography, and revascularization (percutaneous coronary interven- 
tion=PCI; coronary bypass surgery=CABG) after discharge (via standardized telephone 
intervwv) were recorded for 3844 hospital discharge survivors at I-year follow-up. 
Results: One-year cumulative mortality was 9.2%. Treatment and unadjusted outcomes 
post-discharge for 3844 hospital swivors, classified by index discharge ACS diagnosis, 
were as follows: 
Post-discharge to 1 All Q Wave Ml Non-Q MI UA (41%) 
year patients (27%) (32%) 
Death 7.2% 6.5% 10%’ 5.4% 
(re) MI 2.9% 2.7% 3.7% 2.6% 
Unstable Angina 8.0% 5.8% 6.4% 11%’ 
Angiography 14% 15% 13% 14% 
PCI 6.8% 6.6% 6.6% 7.2% 
CABG 3.9% 4.3% 4.3% 3.3% 
* p< 0.001 
Conclusions: Despite similar rates of in-hospital and post-discharge coronary angiogra- 
phy and revascularuation. unadjusted l-year mortality was higher in patients with non-Q 
wave Ml. This suggests that more aggressive therapy, including re-allocation of limited 
resources towards management of these high-risk patients, may be required. 
1072-102 Multiple Clinical Risk Factors Do Not Preclude 
Immediate Exercise Testing in a Chest Pain Evaluation 
Unit 
Ezra A. Amsterdam, Deborah Diercks, J. Douglas Kirk, University of California, Davis, 
Medical Center, Sacramento, CA 
BACKGROUND: In pabents (Pts) presenting with chest pain suggestive of acute coro- 
nary syndrome (ACS), low risk is associated with a nonischemic imtial electrocardiogram 
and negative serum cardiac marker. To further refine risk assessment of these Pts. addi- 
tional clinical factors (ACF) have been utilized, as in the TIMI risk score. It has been sug- 
gested that Pts with aggregation of these risk factors should not be evaluated by an 
accelerated protocol in a chest pain evaluation unit (CPEU) because of a higher rats of 
ACS in this group. In our CPEU, we employ immediate exercise testing (IET) in Pts con- 
sidered low or intermediate risk based on the initial ECG and cardiac serum marker. We, 
therefore, reviewed our experience in Pts with ACF. 
METHODS: All Pts admItted to the CPEU had a normal initial ECG and negative initial 
serum troponin I or myoglobln. We determlned the relationship to Pt outcome of 2 1 of 
the following ACF: previously documented coronary artery disease, advanced age (>65 
yr) and presence of 2 3 CAD risk factors. Final diagnosis of ACS was based on evidence 
of CAD by further cardiac study (stress imaging or angiography) or occurrence of myo- 
cardlal InfarctIon, revascularization or cardiac death during CPEU stay or 30 day follow- 
up (FU) period. 
RESULTS: IET was performed in 1808 consecutive Pts (919 men, 889 women. mean 
age 54 yr.) and was negative for lschemla in 65% (1168) of Pts. non-diagnostic (ND) in 
RR of recurrent ischemic events after MI in different time periods 
1979. 1984-1988 1989-l 993 1994-l 998 
1963 
Recurrent MI 
1 .oo 0.85 0.76 0.79 
(Cl 0.68-l .07) (Cl 0.60-0.96) (Cl 0.62-1.02) 
Unstable angina 
1 .oo 0.84 0.93 0.81 
(Cl 0.71-1.01) (Cl 0.78-1.10) (Cl 0.68-0.97) 
SCD 
1.00 1.04 0.87 0.40 
(Cl 0.75-l .45) (Cl 0.61-I .26) (Cl 0.24-0.67) 
Any event 
1 .oo 0.89 0.89 0.76 
(Cl 0.76-1.04) (Cl 0.76-1.04) (Cl 0.66-0.93) 
1072-104 The TIMI Risk Index Predicts Long-Term Mortality in 
Patients Admitted With Primary Unstable Angina 
David O’Halloran Christopher J. O’Donnell. Robert P. Giugliano, Carlos A. Camargo, Jr., 
Larry Allen, Donald M. Lloyd-Jones, Massachusetts General Hospital, Boston, MA 
Background:The Thrombolysis In Myocardial lschemia (TIMI) risk index - [(heart rate x 
(agellO~)isystolic blood pressure] has been shown to be a strong and independent 
predictor of 30.day mortality in selected patients presenting with ST-elevation MI, but its 
utility for unselected patients presenting with unstable angina (UA) and its ability to pre- 
dict long term outcomes are unknown. 
Methods: We updated a pre-existing database of 280 unselected patients with primary 
UA admitted via the Emergency Department to a large, urban academic hospital in 1991- 
1992. We calculated the TIMI risk index for each patient based on values at presentation 
and used Cox models to assess the ability of the risk Index to predict long-term mortality. 
Results: There were 275 patients (age 66+12 years, 33% women) who survived to hos- 
pital discharge. Post-discharge death was documented in 134 patients. VItaI status was 
known for >99% of patients at 1 year, 86% at 5 years and 77% at 10 years. Median fol- 
low-up for patients who did not die was 9.4 years. The mean risk index was 23tlO points 
(range 5-65). The risk index was a strong predictor of l-year and lo-year mortality 
(p=O.OOZ). For each lo-point increase in the risk index, the hazard ratio for one year mor- 
tality was 1.61 (95% Cl 1.23 - 2.10) and the hazard ratio for 10 year mortality was 1.72. 
(95% Cl 1.51 - 1.96). We found optimal discrimination for 1 O-year mortality using a cut- 
point of 21 points (=21 vs. ~21: hazard ratio (HR) 4.3, 95% Cl 2.9-6.4). Compared with 
the lowest quintile of risk index, the HR for lo-year mortality for the highest qulntile was 
5.5 (95% Cl 3.0-10.0). After multivariable adjustment for other known predictors of lo- 
year mortality (CHF. elevated creatinine or kukocytosis at presentation, history of diabe- 
tes mellitus or Ml), the risk index remained a significant predictor of 1 O-year moltality (HR 
for lo-point increase: 1.5, 95% Cl 1.3-l 3). 
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Conclusions: The TIMI risk index provides excellent prediction of long-term mortality 
after hospitalization with primary UA. independent of other variables. Our findmgs extend 
the utility of this risk index to unselected patients with UA and to long-term risk prediction. 
JACC March 19,2003 
1072-l 05 Impact of Diabetes Mellitus on Long-Term Outcome 
After Non-ST-Elevation Acute Coronary Syndromes 
Treated With Very Early Revascularization 
ChristIan Mueller, Franz-Josef Neumann, Helmut Roskamm, Andre P. Perruchoud, 
Heinz J. Buettner, University Hospital, Easel, Switzerland, Hew-Zentrum, Bad 
Krozingen, Germany 
Background: Limited informatlon is available regarding the outcome of diabetic patients 
treated with very early revascularizatlon for no-ST-elevation acute coronary syndromes 
(NSTACS). Methods: We conducted a prospective cohort study in 270 diabetics and 
1163 nondiabetics with NSTACS undergoing coronary angiography and subsequent 
revascularizatlon within 24 hours of admission. The primary endpoint was all-cause mor- 
tality and recorded for a mean of 20 months. Results: There were important differences 
in baselme characteristics. Most importantly, diabetics were older, and more often had 
previous myocardial Infarction and three vessel disease as compared with nondiabetics. 
In addition, the NSTACS was more severe in diabetics, as cardiopulmonary resuscita- 
tion, ST-segment depression and raised Troponin T occurred more ofien in diabetics. 
Consequently, in-hospital (4.1% versus 1.3%, hazard ratio 3.47: 95% Cl, 1.57 to 7.64; 
p=O.OOZ) and long-term mortality (9.7% versus 4.9%, hazard ratio 2.1 I; 95% Cl, 1.33 to 
3.36; p=O.OOZ) were significantly higher In diabetics. However, after adjustment for these 
differences in baseline characteristics, diabetes was no longer an independent predictor 
of long-term morialtty (hazard ratio 1.43; 95% Cl, 0.74 to 2.78; p=O.292). The prognostlc 
impact of diabetes was different in women and men. Conclusion: Diabetic patients with 
NSTACS do have a higher in-hospital and long-term mortality due to their more 
advanced CAD and more severe NSTACS. However, very early revascularizatlon seems 
to improve outcome in patients with diabetes and compensate for much of the extra risk 
factors present particular in diabetic women. 
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1073-89 Escalating Energy Is More Effective Than Fixed Energy 
Defibrillation for Ischemically Induced Ventricular 
Fibrillation 
Emad Khaleeli, James T. Niemann, Robert G. Walker, John P. Rosborough, Harbor- 
UCLA MedIcal Center, Torrance, CA 
Background: Defibrillation, the principle challenge for out-of-hospital resuscitation, is 
best studted in clinically relevant models. Electrically induced VF in animals with charac- 
teristically low transthoracic impedance (TTI) (30.500) is readily terminated by lower 
energy (15OJ) shocks. We hypothewed that a model of ischemic VF combined with TTI 
more typical of humans would require higher energy shocks for defibrillation. Methods: 
18 anesthetized swine were randomized to fixed, low energy (15OJ) transthoracic shocks 
(Group 1, n=9) or escalating, higher energy (ZOO-300-36OJ) shocks (Group 2, n=9). 
Thirty ohms were added in series to the measured TTI (obtained during a 3OJ shock 
while in sinus rhythm) of each pig. A multielectrode-tipped catheter was positioned in the 
coronary sinus for determination of electrical field strength (V/cm) produced by each tran- 
sthoracic shock. VF was then induced by percutaneous balloon occlusion of a coronary 
artery. After 1 minute or 5 minutes of VF, countershocks with a biphasic truncated expo- 
nential waveform were administered at end-expiration using adhesive electrodes applied 
to the left and right lateral thorax. The primary endpoint was successful defibrillation with 
<3 shocks. 
Results: The mean TT was not different between the groups (Group 1,82~110; Group 
2, 84+7 0), nor was the first shock peak current (Group 1, 18.1*1.2 A; Group 2, 20.3kO.l 
A). Only one of the group 1 animals (11%) could be defibrillated with up to 3 shocks, 
each at 150 J. All Group 2 animals were successfully defibrillated. Eight of 9 group 2 ani- 
mals were defibrillated with < 2 shocks (p<O.OOl YS Groupl). The negative predictive 
value of a field strength of cl0 V/cm was 100%. 
Conclusions: In this ischemically induced VF animal model, 1. fixed, lower energy 
shocks were less effective than higher energies administered in an escalating dose pro- 
tocol. 2. the effective energy dose for defibnllation was higher than that reported in elec- 
trically induced VF models, and 3. the electric field strength required for transthoracic 
deftbrillation was greater than 10 V/cm and a value less than this was predictive of 
defibrillation failure. 
1073-90 Comparison of Weight-Based Monophasic and Fixed- 
Sequence Biphasic Defibrillation Dosing for 
Resuscitation in a Model of Pediatric Prolonged Cardiac 
Arrest 
Robert A. Berg, Ronald W. Hilwig, Fred W. Chapman, Robert G. Walker, Richard C. 
Nova, Marc D. Berg, Karl B. Kern, Gordon A. Ewy, University of Arizona, Tucson, AZ, 
Medtronic Physio-Control Corp., Redmond, WA 
Background: Standard therapy for patients under 8 years old in ventricular fibnllation 
(VF) is to shock with a weight-based defibrillation dose. Since weight-based dosing is not 
feasible for automated external defibdllators (AEDs), it is important to learn If a single 
escalating energy sequence IS effective over the weight range of children under 8. 
Methods: After 7 minutes of untreated VF, 4. 14 and 24 kg piglets (10 of each weight) 
were randomized to receive monophasic 2,4,4 J/kg therapy (M) or a biphasic sequence 
of 50, 75, 86 J (B). Resuscitation was per peds BLS protocol to 20 minutes, then peds 
ALS protocol to 27 minutes. Endpoints 4.hr survival and 24.hr survival with good neuro- 
logical outcome (cerebral performance category 1 or 2) were analyzed by Fisher’s exact 
test; energy and number of shocks were analyzed by Student‘s t-test. 
Results: Many more M than B shocks failed to defibrillate the first episode of VF (12 * 7 
vs. 2 * 3 failed shocks, p<O.OOl) resulting in higher cumulative energy for M than B (59 * 
29 vs. 24 * 24 J/kg, p=O.OOl). More B than M piglets survived to 4 hrs (1505 vs. 7/i& 
p=O.OOZ) and subsequently surwved to 24 hours with good neuro scores (14/15 vs. 5115, 
p=O.O02). Most non-survivors had refractory VF. 
Conclusions: This study showed that a smgle escalating biphasic dosing sequence con- 
sistently resuscitates piglets after prolonged VF, an important issue for pediatric AEDs. 
This therapy produced outcome superior to the recommended monophasic weight-based 
dosing over a wide weight range. 
4 kg Weight 14 kg Weight 24 kg 
Weight 
M B M B M B 
Cumulative delivered energy, J/kg, 50+ 42- 40 * 21- 88* s-4 
mean * sd 19 22 32 28 6 
# Failedshocks, 15’VFep~sode. 10 * 0.2 - 8.6 * 3.4- t8* 2 - 
mean r sd 6 0.4 7.4 5.5 2 1.4 
4.hrsurvival 315 55 315 !z l/5 55 
Good 24.hr neuro Z/5 415 315 ytj o/5 5/?j 
1073-91 Detection and Discrimination Performance of an 
Automatic External Defibrillator in Ambulatory Patients 
During Treadmill Exercise 
Thomas A. Matiioni, Sue Welch, Nabil Kansan, Wendy Miller, Don Lin, Arizona Heart 
Institute, Phoenix, AZ, Cardiac Science, Inc., Irvine, CA 
The Powerhearl CRM (Cardiac Rhythm Monitor) is the next generation automatic exter- 
nal cardioverter defibrillator (AECD) deslgned for in-hospital use. This AECD has a pro- 
grammable supraventricularlventricular tachycardia (SVTNT) discrimination algorithm 
designed to inhibit therapy delivery in the presence of SVT. This algorithm is also incor- 
porated into the Powerheart AED (Automatic External Defibrillator) designed for out of 
hospltal, first responder use. The present study was performed to assess algorithm per- 
formance in ainbulatory p&tents. 
A total of 50 participants (50 Males) in a cardiac rehabilitation program were attached to 
the AECD via externally applied adhesive electrode pads In the sternum-apex configura- 
tlon. It was programmed to dwximinate SVT from VT withln a heart rate zone of 120 to 
200 bpm in the advisory mode. Patients then walked on a conventional treadmill until lim- 
ited by symptoms. Patients exercised for 7 to 15 minutes at a speed of 3.0 to 5.0 mph at 
0 to IO degrees grade. Only 22 patients achwed peak heart rates of greater than 120 
bpm (mean peak heart rate 134 bpm). There were 4 episodes of artifact detection but no 
advice for therapy delivery in these 22 patients. There was one episode of recommended 
shock delivery at peak exercise at 7 minutes and heart rate of 106 bpm. This resulted in 
a specificity of 95.6%. In conclusion, this algorithm was very successful in rejecting arti- 
fact and discriminating SVT from VT during symptom-limited exertion and would be 
expected to perform very well In ambulatory patients. 
1073-92 Hypothermia Facilitates Transthoracic Defibrillation 
Beniamin J. Rhee, Yi Zhang, Loyd R. Davies, Richard E. Kerber, University of Iowa, Iowa 
City, IA 
Background: Induced hypothermia (H) appears a promising intenention to protect the 
heart during and after resuscitation from cardiac arrest. However, the influence of H on 
defibrillation energy requirements IS not well characterized. We studied the effect of body 
hypothermia on transthoracic defibrillation energy requirements, transthoraclc impe- 
dence (TTI) and current using a swine model. 
Methods: In 8 animals (21.4 * 1.3(SE) kg) ventricular fibrillation (VF) was induced by 
delivery of 60 Hz AC current to the right ventricular apex. After 30 seconds of VF, the nor- 
mothermic (N) swine were defibrillated (biphasic waveform) at ZOJ. 3OJ, 5OJ, and IOOJ. 
The swine were cooled to 30” C by surroundmg the head, thorax, and abdomen with ice, 
and then underwent defibrillation at the same energies. 
Results: Shock success I” terminating VF was higher during H (pcO.001, odds ratio 3.98, 
95% Cl: 1.95, 8.12), despite the fact that TTI rose from 39 f 3 (SD) ohms (N) to 42 f 3 
(SD) ohms (H) (pcO.001) and current fell from 22 d 8 (N) to 21 * 7 Amperes (H) 
(pcO.001). Post-defibrillation asystole occurred In 3 of 8 swine (N) vs. 0 of 8 (H) (pcO.05). 
